Section Arrow
Quote
PTIX.NASDAQ
- Protagenic Therapeutics Inc
Quotes are at least 15-min delayed:2025/08/27 14:02 EDT
Regular Hours
Last
 3.9
-0.07 (-1.76%)
Day High 
4.075 
Prev. Close
3.97 
1-M High
6.2 
Volume 
169.11K 
Bid
3.9
Ask
3.95
Day Low
3.84 
Open
3.9 
1-M Low
2.25 
Market Cap 
3.45M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 3.34 
20-SMA 3.1 
50-SMA 3.34 
52-W High 217.5404 
52-W Low 2.25 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-13.13/-0.61
Enterprise Value
3.77M
Balance Sheet
Book Value Per Share
-0.10
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
NBYNovaBay Pharmaceuticals1.59+0.69105+76.87%0.55PE
TNFATNF Pharmaceuticals Inc.0.088+0.0101+12.97%-- 
AZTRAzitra0.9964+0.2384+31.45%0.03PE
BTAIBioXcel Therapeutics Inc4.05-1.19-22.71%-- 
MBRXMoleculin Biotech0.5772+0.0317+5.81%-- 
Quotes are at least 15-min delayed：2025/08/27 14:02 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's main compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.